RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Novartis AG

A collection of news and information related to Novartis AG published by this site and its partners.

Top Novartis AG Articles see all

Displaying items 1-5
  • Pfizer walks away from AstraZeneca takeover attempt

    Pfizer walks away from AstraZeneca takeover attempt
    Pfizer Inc. said Monday that it had abandoned its current attempt to buy AstraZeneca PLC for nearly $118 billion — a deal watched warily by Maryland officials — as a deadline approached without a last-minute change of heart by the British drugmaker.
  • Asthma drug calms chronic hives, rashes

    Sufferers of chronic hives and rashes could benefit from a commonly-used asthma drug, Johns Hopkins researchers have found. Scientists found that a once-a-month dose of the drug omalizumab helped ease symptoms that standard antihistamines didn't....

    Seasonal flu vaccine may fall short

    Seasonal flu vaccine may fall short
    With all the attention given to the slow pace of distribution of the swine flu vaccine, doctors and other providers are raising concerns about a shortage of vaccine for the other flu that is expected to slam the state and country this year. Demand...

    'Most exciting ever' Novartis drug points to huge sales

    BARCELONA (Reuters) - Sales forecasts for Novartis's new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease. Shares in the Swiss...

    New Novartis drug may upend heart failure treatment

    BARCELONA (Reuters) - A new medicine from Novartis could replace drugs that have been central to treating heart failure for a quarter of century, after proving remarkably effective in reducing deaths in a keenly awaited study. The experimental treatment,...